Drugs give FTSE a lift

clock

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen 0.62% to 200.5p after HSBC rated it as "overweight" with a price target of 240p. Sainsbury has been started with an 'underweight' recommendation and has fallen 0.22% to 334.25p. In Japan, the Nikkei 225 Stock Average added 66.88 points, or 0.4%, to 15,638.5 points as a US manufacturing report fuelled speculation the Federal Reserve might refrain from raising interest rates. Sony gain...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Future of Investment Festival: Our specialist sessions for advisers

Future of Investment Festival: Our specialist sessions for advisers

Future-proofing advice, building sustainable portfolios, all things SDR

Professional Adviser
clock 19 April 2024 • 2 min read
Why non-transparent managers are behind most failed acquisitions

Why non-transparent managers are behind most failed acquisitions

‘They don’t understand the importance of culture and cohesion’

Rami Cassis
clock 12 April 2024 • 3 min read
Partner Insight: Understanding the investment universe

Partner Insight: Understanding the investment universe

Invesco
clock 12 April 2024 • 6 min read